These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34443334)

  • 41. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
    Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
    Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-tuberculosis activity and its structure-activity relationship (SAR) studies of oxadiazole derivatives: A key review.
    Verma SK; Verma R; Verma S; Vaishnav Y; Tiwari SP; Rakesh KP
    Eur J Med Chem; 2021 Jan; 209():112886. PubMed ID: 33032083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Triazole-containing hybrids with anti-
    Tan Z; Deng J; Ye Q; Zhang Z
    Future Med Chem; 2021 Apr; 13(7):643-662. PubMed ID: 33619989
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and antituberculosis activity of some new 2-quinoxalinecarbonitriles.
    Montoya ME; Sainz Y; Ortega MA; Lopez De Cerain A; Monge A
    Farmaco; 1998; 53(8-9):570-3. PubMed ID: 10081819
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.
    Zanetti S; Sechi LA; Molicotti P; Cannas S; Bua A; Deriu A; Carta A; Paglietti G
    Int J Antimicrob Agents; 2005 Feb; 25(2):179-81. PubMed ID: 15664491
    [No Abstract]   [Full Text] [Related]  

  • 47. New direct inhibitors of InhA with antimycobacterial activity based on a tetrahydropyran scaffold.
    Pajk S; Živec M; Šink R; Sosič I; Neu M; Chung CW; Martínez-Hoyos M; Pérez-Herrán E; Álvarez-Gómez D; Álvarez-Ruíz E; Mendoza-Losana A; Castro-Pichel J; Barros D; Ballell-Pages L; Young RJ; Convery MA; Encinas L; Gobec S
    Eur J Med Chem; 2016 Apr; 112():252-257. PubMed ID: 26900657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives.
    Peng CT; Gao C; Wang NY; You XY; Zhang LD; Zhu YX; Xv Y; Zuo WQ; Ran K; Deng HX; Lei Q; Xiao KJ; Yu LT
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1373-6. PubMed ID: 25754492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of new riminophenazine analogues as antimycobacterial agents against drug-resistant Mycobacterium tuberculosis.
    Zhao X; Mei Y; Guo Z; Si S; Ma X; Li Y; Li Y; Song D
    Bioorg Chem; 2022 Nov; 128():105929. PubMed ID: 35701239
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antimycobacterial and anti-inflammatory activities of thiourea derivatives focusing on treatment approaches for severe pulmonary tuberculosis.
    Calixto SD; Simão TLBV; Palmeira-Mello MV; Viana GM; Assumpção PWMC; Rezende MG; do Espirito Santo CC; de Oliveira Mussi V; Rodrigues CR; Lasunskaia E; de Souza AMT; Cabral LM; Muzitano MF
    Bioorg Med Chem; 2022 Jan; 53():116506. PubMed ID: 34890996
    [TBL] [Abstract][Full Text] [Related]  

  • 51. QSAR analysis for quinoxaline-2-carboxylate 1,4-di-N-oxides as anti-mycobacterial agents.
    Vicente E; Duchowicz PR; Castro EA; Monge A
    J Mol Graph Model; 2009 Aug; 28(1):28-36. PubMed ID: 19394254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent Advances in Medicinal Chemistry to Treat Tuberculosis - Part-II.
    Srivastava SK
    Curr Top Med Chem; 2019; 19(9):645. PubMed ID: 31274062
    [No Abstract]   [Full Text] [Related]  

  • 53. Drug development against tuberculosis: Impact of alkaloids.
    Mishra SK; Tripathi G; Kishore N; Singh RK; Singh A; Tiwari VK
    Eur J Med Chem; 2017 Sep; 137():504-544. PubMed ID: 28628823
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exploring 3-arylquinoxaline-2-carbonitrile 1,4-di-N-oxides activities against neglected diseases with QSAR.
    Vicente E; Duchowicz PR; Ortiz Edel V; Monge A; Castro EA
    Chem Biol Drug Des; 2010 Jul; 76(1):59-69. PubMed ID: 20492446
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coumarin as a Privileged and Medicinally Important Scaffold in the Treatment of Tuberculosis.
    Gupta V; Ambatwar R; Bhanwala N; Khatik GL
    Curr Top Med Chem; 2023; 23(16):1489-1502. PubMed ID: 37005527
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis of novel [1,2]-diamines with antituberculosis activity.
    Meng Q; Luo H; Chen Y; Wang T; Yao Q
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quinoxaline 1,4-di-
    Palos I; González-González A; Paz-González AD; Espinoza-Hicks JC; Bandyopadhyay D; Paniagua-Castro N; Galeana-Salazar MS; Castañeda-Sánchez JI; Luna-Herrera J; Rivera G
    Molecules; 2024 Sep; 29(19):. PubMed ID: 39407582
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A macrolactone from benzo[a]phenazine with potent activity against Mycobacterium tuberculosis.
    Silva RS; Pinto Mdo C; Goulart MO; de Souza Filho JD; Neves I; Lourenço MC; Pinto AV
    Eur J Med Chem; 2009 May; 44(5):2334-7. PubMed ID: 18662840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent developments of coumarin-containing derivatives and their anti-tubercular activity.
    Hu YQ; Xu Z; Zhang S; Wu X; Ding JW; Lv ZS; Feng LS
    Eur J Med Chem; 2017 Aug; 136():122-130. PubMed ID: 28494250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An appraisal of anti-mycobacterial activity with structure-activity relationship of piperazine and its analogues: A review.
    Girase PS; Dhawan S; Kumar V; Shinde SR; Palkar MB; Karpoormath R
    Eur J Med Chem; 2021 Jan; 210():112967. PubMed ID: 33190957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.